Flow Cytometry Quality Controls
Trusted Performance for Immunophenotyping and Cell Therapy
Flow cytometry failures rarely announce themselves. Instrument drift, lot variability and laser alignment shifts happen silently until a misclassified blast population or missed lymphocyte subset affects a patient. Catching those failures requires controls purpose-built for the complexity of flow cytometry. Streck provides quality controls that deliver extended stability, comprehensive marker coverage and platform-independent verification.
Why Streck for Flow Cytometry QC
Streck’s flow cytometry controls are built from deep disciplinary focus, not broad product coverage.
- Extended Stability
90-day shelf life means fewer lot changes and less correlation downtime, with consistent lot-to-lot performance and room temperature storage that eliminates cold-chain complexity. - Comprehensive Coverage
50+ markers spanning lymphocyte subsets, blast populations, stem cells and specialized panels, with normal and abnormal populations in a single control that often covers multiple panels. - Platform-Independent Verification
Works across BD® Biosciences and Beckman Coulter® platforms, independent of instrument and reagent manufacturers and meets CAP requirements for external third-party quality control.
Partnership That Strengthens YOUR Quality
Flow cytometer manufacturers and reagent developers partner with Streck to provide comprehensive third-party QC. Founded in 1971, Streck pioneered stabilized blood controls with decades of proven performance in clinical laboratories. Laboratories using BD Biosciences and Beckman Coulter platforms rely on CD-Chex controls for diagnostic immunophenotyping and cell therapy release testing.
Flow Cytometry Quality Control Portfolio
STATS® Interlaboratory Quality Control
Streck’s free STATS® program enables laboratories to compare QC performance against peer groups using the same controls and instruments.
